Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Tyrosine Kinase Inhibitor market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Tyrosine Kinase Inhibitormarket, defines the market attractiveness level of Tyrosine Kinase Inhibitor market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Tyrosine Kinase Inhibitor industry, describes the types of Tyrosine Kinase Inhibitor market, the applications of major players and the market size, and deeply analyzes the current situation of the global Tyrosine Kinase Inhibitor market and the development prospects and opportunities of Tyrosine Kinase Inhibitor industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Tyrosine Kinase Inhibitor market in Chapter 13.
By Player:
Tolero Pharmaceutical
Pfizer
Biogen Idec
Merck
GalaxoSmithKline
Johnson & Johnson
Novartis
Sanofi
Bayer Healthcare Pharmaceuticals
By Type:
Phase-I
Phase-I/II
Phase-II
Phase-II/III
Phase-III
By End-User:
Breast Cancer
Glioblastoma and Lung Cancer
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Tyrosine Kinase Inhibitor Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Tyrosine Kinase Inhibitor Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Tyrosine Kinase Inhibitor Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Tyrosine Kinase Inhibitor Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Tyrosine Kinase Inhibitor Market Analysis and Outlook to 2022
-
7.1 Global Tyrosine Kinase Inhibitor Consumption (2017-2022)
-
7.2 United States Tyrosine Kinase Inhibitor Consumption (2017-2022)
-
7.3 Europe Tyrosine Kinase Inhibitor Consumption (2017-2022)
-
7.4 China Tyrosine Kinase Inhibitor Consumption (2017-2022)
-
7.5 Japan Tyrosine Kinase Inhibitor Consumption (2017-2022)
-
7.6 India Tyrosine Kinase Inhibitor Consumption (2017-2022)
-
7.7 South Korea Tyrosine Kinase Inhibitor Consumption (2017-2022)
8 Region and Country-wise Tyrosine Kinase Inhibitor Market Analysis and Outlook to 2028
-
8.1 Global Tyrosine Kinase Inhibitor Consumption Forecast (2022-2028)
-
8.2 United States Tyrosine Kinase Inhibitor Consumption Forecast (2022-2028)
-
8.3 Europe Tyrosine Kinase Inhibitor Consumption Forecast (2022-2028)
-
8.4 China Tyrosine Kinase Inhibitor Consumption Forecast (2022-2028)
-
8.5 Japan Tyrosine Kinase Inhibitor Consumption Forecast (2022-2028)
-
8.6 India Tyrosine Kinase Inhibitor Consumption Forecast (2022-2028)
-
8.7 South Korea Tyrosine Kinase Inhibitor Consumption Forecast (2022-2028)
9 Global Tyrosine Kinase Inhibitor Market Outlook by Types and Applications to 2022
-
9.1 Global Tyrosine Kinase Inhibitor Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Phase-I Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Phase-I/II Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Phase-II Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Phase-II/III Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Phase-III Consumption and Growth Rate (2017-2022)
-
9.2 Global Tyrosine Kinase Inhibitor Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Glioblastoma and Lung Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Tyrosine Kinase Inhibitor Market Outlook by Types and Applications to 2028
-
10.1 Global Tyrosine Kinase Inhibitor Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Phase-I Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Phase-I/II Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Phase-II Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Phase-II/III Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Phase-III Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Tyrosine Kinase Inhibitor Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Glioblastoma and Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Tyrosine Kinase Inhibitor Import and Export Analysis (Top 5 Countries)
-
11.1 Global Tyrosine Kinase Inhibitor Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Tyrosine Kinase Inhibitor Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Tyrosine Kinase Inhibitor Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Tyrosine Kinase Inhibitor Market Competitive Analysis
-
14.1 Tolero Pharmaceutical
-
14.1.1 Tolero Pharmaceutical Company Details
-
14.1.2 Tolero Pharmaceutical Tyrosine Kinase Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Tolero Pharmaceutical Tyrosine Kinase Inhibitor Product and Service
-
14.2 Pfizer
-
14.2.1 Pfizer Company Details
-
14.2.2 Pfizer Tyrosine Kinase Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Pfizer Tyrosine Kinase Inhibitor Product and Service
-
14.3 Biogen Idec
-
14.3.1 Biogen Idec Company Details
-
14.3.2 Biogen Idec Tyrosine Kinase Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Biogen Idec Tyrosine Kinase Inhibitor Product and Service
-
14.4 Merck
-
14.4.1 Merck Company Details
-
14.4.2 Merck Tyrosine Kinase Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Merck Tyrosine Kinase Inhibitor Product and Service
-
14.5 GalaxoSmithKline
-
14.5.1 GalaxoSmithKline Company Details
-
14.5.2 GalaxoSmithKline Tyrosine Kinase Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 GalaxoSmithKline Tyrosine Kinase Inhibitor Product and Service
-
14.6 Johnson & Johnson
-
14.6.1 Johnson & Johnson Company Details
-
14.6.2 Johnson & Johnson Tyrosine Kinase Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Johnson & Johnson Tyrosine Kinase Inhibitor Product and Service
-
14.7 Novartis
-
14.7.1 Novartis Company Details
-
14.7.2 Novartis Tyrosine Kinase Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Novartis Tyrosine Kinase Inhibitor Product and Service
-
14.8 Sanofi
-
14.8.1 Sanofi Company Details
-
14.8.2 Sanofi Tyrosine Kinase Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Sanofi Tyrosine Kinase Inhibitor Product and Service
-
14.9 Bayer Healthcare Pharmaceuticals
-
14.9.1 Bayer Healthcare Pharmaceuticals Company Details
-
14.9.2 Bayer Healthcare Pharmaceuticals Tyrosine Kinase Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Bayer Healthcare Pharmaceuticals Tyrosine Kinase Inhibitor Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Tyrosine Kinase Inhibitor
-
Figure Tyrosine Kinase Inhibitor Picture
-
Table Global Tyrosine Kinase Inhibitor Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Tyrosine Kinase Inhibitor Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Tyrosine Kinase Inhibitor Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Tyrosine Kinase Inhibitor Consumption by Country (2017-2022)
-
Figure United States Tyrosine Kinase Inhibitor Consumption and Growth Rate (2017-2022)
-
Table Europe Tyrosine Kinase Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure China Tyrosine Kinase Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure Japan Tyrosine Kinase Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure India Tyrosine Kinase Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure South Korea Tyrosine Kinase Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure Global Tyrosine Kinase Inhibitor Consumption Forecast by Country (2022-2028)
-
Figure United States Tyrosine Kinase Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Tyrosine Kinase Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Tyrosine Kinase Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Tyrosine Kinase Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Tyrosine Kinase Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Tyrosine Kinase Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Phase-I Consumption and Growth Rate (2017-2022)
-
Figure Global Phase-I/II Consumption and Growth Rate (2017-2022)
-
Figure Global Phase-II Consumption and Growth Rate (2017-2022)
-
Figure Global Phase-II/III Consumption and Growth Rate (2017-2022)
-
Figure Global Phase-III Consumption and Growth Rate (2017-2022)
-
Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Glioblastoma and Lung Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Phase-I Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Phase-I/II Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Phase-II Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Phase-II/III Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Phase-III Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Glioblastoma and Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Tyrosine Kinase Inhibitor Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Tyrosine Kinase Inhibitor Export by Region (Top 5 Countries) (2017-2028)
-
Table Tolero Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Tolero Pharmaceutical Tyrosine Kinase Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tolero Pharmaceutical Tyrosine Kinase Inhibitor Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Tyrosine Kinase Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Tyrosine Kinase Inhibitor Product and Service
-
Table Biogen Idec (Foundation Year, Company Profile and etc.)
-
Table Biogen Idec Tyrosine Kinase Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Idec Tyrosine Kinase Inhibitor Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Tyrosine Kinase Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Tyrosine Kinase Inhibitor Product and Service
-
Table GalaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GalaxoSmithKline Tyrosine Kinase Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table GalaxoSmithKline Tyrosine Kinase Inhibitor Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Tyrosine Kinase Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Tyrosine Kinase Inhibitor Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Tyrosine Kinase Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Tyrosine Kinase Inhibitor Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Tyrosine Kinase Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Tyrosine Kinase Inhibitor Product and Service
-
Table Bayer Healthcare Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Bayer Healthcare Pharmaceuticals Tyrosine Kinase Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Healthcare Pharmaceuticals Tyrosine Kinase Inhibitor Product and Service
-
